Dow Inc.
NYSE:DOWChemicals
-$0.84 today
- Market cap
- $21.98B
- Beta
- 0.41
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$3.83
- Dividend yield
- 4.42%
Volume 6.32M
Average 13.17M
DOW Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Dow Inc.NYSE: DOW
Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026
Cash & equivalents falls 10.1% from a year ago
Cash & equivalents stood at $4.14B at the end of Q3 FY2026, down 10.1% from a year earlier and up 4.3% from the prior quarter. Over 3 fiscal years it compounded at -0.6% a year.
Context
- Cash & equivalents amounted to 6.8% of total assets at the end of Q3 FY2026, down 0.8 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -10.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 3.82B USD
- Year-over-year change
- +74.3%
- 4-year CAGR
- +6.3%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.82B | +74.3% |
| FY2024 | 2024-12-31 | 2.19B | -26.7% |
| FY2023 | 2023-12-31 | 2.99B | -23.1% |
| FY2022 | 2022-12-31 | 3.89B | +30.1% |
| FY2021 | 2021-12-31 | 2.99B | — |
Cash & Equivalents vs competitors
How DOW compares with its peers on the latest reported figures
- DOW's Sep 2026 cash & equivalents of $4.14B is the highest of the 10 companies compared; the peer median is $691M.
- Its year-over-year change of -10.1% is the 9th highest of 10, against a peer median of +0.0%.
- Cash & equivalents amounts to 6.8% of total assets for DOW, versus a peer median of 6.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $4.14B | -10.1% | -0.6% | 6.8% | |
| Sep 2026 | $3.23B | +80.9% | +17.0% | 9.3% | |
| Sep 2026 | $1.76B | -8.5% | +6.9% | 9.2% | |
| Jun 2026 | $1.74B | -5.3% | -40.9% | 8.3% | |
| Jun 2026 | $1.36B | +16.3% | -5.7% | 6.4% | |
| Jun 2026 | $691M | +63.4% | +4.7% | 4.5% | |
| Sep 2026 | $445.7M | +0.0% | -7.3% | 7.5% | |
| Mar 2026 | $369M | +10.5% | -13.1% | 5.2% | |
| Jun 2026 | $177.4M | -20.7% | -4.8% | 2.4% | |
| Mar 2026 | $126M | -8.7% | +8.8% | 2.1% | |
| Peer median (excluding DOW) | $691M | +0.0% | -4.8% | 6.4% | |
Competitors are the stored peer set for DOW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.99B | 3.89B | 2.99B | 2.19B | 3.82B |
| Short-term Investments | 0 | 0 | 0 | 383M | 0 |
| Net Receivables | 9.55B | 7.76B | 6.61B | 6.86B | 6.64B |
| Inventory | 7.37B | 6.99B | 6.08B | 6.54B | 6.6B |
| Other Current Assets | 934M | 1.85B | 1.94B | 610M | 1.01B |
| Total Current Assets | 20.85B | 20.48B | 17.61B | 16.59B | 18.06B |
| Property, Plant & Equipment (Net) | 21.97B | 21.67B | 22.39B | 23.27B | 23.61B |
| Goodwill | 8.76B | 8.64B | 8.64B | 8.57B | 7.98B |
| Intangible Assets | 2.88B | 2.44B | 2.07B | 1.72B | 1.49B |
| Long-term Investments | 5.24B | 4.38B | 4.01B | 4.68B | 3.02B |
| Tax Assets | 1.36B | 960M | 1.49B | 1.26B | 1.51B |
| Other Non-current Assets | 1.93B | 2.03B | 1.76B | 1.23B | 2.88B |
| Total Non-current Assets | 42.14B | 40.13B | 40.35B | 40.72B | 40.48B |
| Total Assets | 62.99B | 60.6B | 57.97B | 57.31B | 58.54B |
| Account Payables | 5.58B | 4.94B | 4.53B | 4.85B | 4.15B |
| Short-term Debt | 392M | 724M | 179M | 632M | 312M |
| Tax Payables | 623M | 334M | 419M | 276M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 13.23B | 11.33B | 9.96B | 10.29B | 9.18B |
| Long-term Debt | 13.41B | 13.91B | 14.03B | 14.77B | 16.72B |
| Deferred Tax Liabilities | 506M | 1.11B | 399M | 392M | 364M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 15.09B | 11.22B | 12.56B | 12.09B | 12.52B |
| Total Non-current Liabilities | 31.03B | 28.03B | 28.9B | 29.17B | 31.83B |
| Total Liabilities | 44.25B | 39.36B | 38.86B | 39.46B | 41.02B |
| Common Stock | 8M | 8M | 8M | 8M | 8M |
| Retained Earnings | 20.62B | 23.18B | 21.77B | 20.91B | 16.78B |
| Accumulated OCI | (8.98B) | (7.14B) | (7.68B) | (8.11B) | (7.66B) |
| Other Stockholders Equity | (15M) | 0 | 0 | 0 | 0 |
| Minority Interest | 574M | 529M | 501M | 496M | 1.51B |
| Total Equity | 18.74B | 21.25B | 19.11B | 17.85B | 17.52B |
| Total Debt | 16.14B | 16.71B | 16.45B | 17.65B | 19.6B |
| Net Debt | 13.15B | 12.82B | 13.46B | 15.46B | 15.78B |
Dow Inc.
NYSE:DOW
Intrinsic Alpha fair value
Locked
Current Price
$30.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.